Health Condition 1: null- Ventricular Tachycardia
Conditions
Interventions
Intervention1: Catheter ablation and amiodarone: Interventional arm would be compared to standard amiodarone drug therapy,duration of amiodarone is from randomization to completion of study.
Control I
Sponsors
CARE Hospital
Biosense Webster
Eligibility
Inclusion criteria
Inclusion criteria: more than 18 and less than 85 years of age History of a remote MI of more than 1 month Survival of a ventricular arrhythmic event VT or VF that would mandate placement of an implantable cardioverter-defibrillator Patient cannot afford an ICD and thus has been planned for treatment with Amiodarone Ability to understand the requirements of the study Willingness to adhere to study restrictions and comply with all postprocedural follow-up requirements
Exclusion criteria
Exclusion criteria: Patients with NYHA class IV congestive heart failure Prior ablation for a ventricular arrhythmia Presence of an LV thrombus Contraindication to anticoagulation Inability to access the endocardium because of mechanical mitral and aortic valve Life expectancy of less than 1 year for any medical condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality and Cardiac Arrest and Sustained VTTimepoint: 24 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of subjects that die within 30 days or by the end of the study Total number of ventricular arrhythmic events, compared between the 2 treatment arms. Differences in LV ejection fraction between paired measurements recorded at baseline and 3 months for each patient will be used to test for significant differences between the two treatment arms. Quality of life. Timepoint: 30days 24months 3 months | — |
Countries
India
Contacts
Public ContactDr Narasimhan
CARE Hospital
Outcome results
None listed